Global Clinical Decision Support Systems Market Size, Share, and COVID-19 Impact Analysis, By Product (Standalone CDSS, Integrated EHR with CDSS), By Application (Drug-Drug interactions, Drug allergy alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, Others), By Deliver Mode (Web based Systems, Cloud Based Systems, On-Premise Systems), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030Industry: Healthcare
Global Clinical Decision Support Systems Market Insights Forecasts to 2030
- The Clinical Decision Support Systems Market Size was valued at USD 4.55 Billion in 2021.
- The Market is Growing at a CAGR of 9.1% from 2021 to 2030
- The Worldwide Clinical Decision Support Systems Market is expected to reach USD 10.2 Billion by 2030
- Asia Pacific is expected to grow the fastest during the forecast period
Get more details on this report -
The Global Clinical Decision Support Systems Market Size is expected to reach USD 10.2 Billion by 2030, at a CAGR of 9.1% during the forecast period 2021 to 2030.
Clinical decision support system is basically an administrative and clinical tool which helps to improve the operational efficiency of medical practices. Healthcare facilities need to handle huge data of patient information including administrative and clinical information. Thus, to handle such huge information, healthcare professionals as well as front office staff are always in search of a method to record, save, and improve the patient information access in an effective way. A clinical decision support system helps the healthcare professionals as well as patients in streamlining the process of medical practices and increase the operational efficiency and patient care.
COVID 19 Impact on Global Clinical Decision Support Systems Market
With the outbreak of the COVID-19 pandemic, the healthcare system across the world was mainly dependent on online services. Most of people across the world are opting for virtual consultation due to the increasing number of infections due to COVID-19. The main reason behind this is the strict lockdown regulation implemented by different governments at the early stages of the pandemic. In addition due to the onset of COVID 19 the clinical decision support system played a significant role to assist patient resources and services. For instance, according to the article published by Journal Plos One, the manufacturing of decision support equipment to track real-time clinical diagnosis of COVID-19 is a must to help patients to allocate resources for patients who are at high risk. In fact, various countries are highly opting for online services which are driving the market. Moreover different market players have introduced clinical decision support system to manage the data and insights of covid-19. For instance, in May 2022, Epocrates introduced a COVID-19 tool which provides late-breaking updates to expand the database.
Global Clinical Decision Support Systems Market Report Coverage
|Market Size in 2021:||USD 4.55 Billion|
|Forecast Period 2021-2030 CAGR:||9.1%|
|2030 Value Projection:||USD 10.2 Billion|
|Historical Data for:||2017-2020|
|No. of Pages:||200|
|Tables, Charts & Figures:||100|
|Segments covered:||By Product, By Application, By Deliver Mode, By Region, COVID-19 Impact Analysis|
|Companies Covered:||Cerner Corporation, McKesson Corporation, Allscripts Healthcare, LLC, Siemens Healthineers GmbH, NextGen Healthcare Inc., Athenahealth, Inc., Koninklijke Philips N.V., Agfa Gevaert Group, IBM Corporation, Wolers Kluwer N.V.|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
Key Market Drivers
Increasing demand for reducing healthcare expenses to drive the market
Certain reasons such as rise in the demand for reducing Healthcare expenses, the importance of improving the quality of treatment, and the advancement in technology in the field of Healthcare IT in hospitals are contributing the growth of the clinical decision support systems market. In addition, as per the Organization for Economic Cooperation and Development (OECD) Survey Report in 2021, the average per capita health expenses was around USD 7,382.6 in Germany, USD 6262.3 in Sweden, and USD 7064.8 in Norway. The increasing healthcare expenses is also anticipated to drive the market growth.
Increasing geriatric population is driving the market
The increasing number of geriatric people is anticipated to drive the overall growth of the market. As the report published by WHO, in October 2022, the people who are aged 60 years and more will increase to 1.4 billion by the year 2030 and is anticipated to reach 2.1 billion by 2050. On the other hand, the UN report in 2022 states that the people above 65 years of age is anticipated to increase from 10% in the year 2022 to 16% in 2050. The geriatric people are prone to chronic diseases and require regular treatments and health checkups to prevent such diseases is anticipated to drive the advanced clinical decision support system market growth.
Government initiatives will propel the market growth
In addition, the increasing number of strategic initiatives taken by governments and private companies like partnerships and collaborations with an aim to develop clinical decision support systems are anticipated to drive the overall growth of the clinical decision support systems market. For instance, in June 2021, Google cloud signed a multi year agreement with the national hospital chain HCA healthcare for creating customized healthcare algorithms to boost clinical decision making.
Lack of trust in the systems to hinder the market growth
The lack of trust in the systems because CDSS are the initial stages of development, lack of skilled professionals and suggestions from CDSS for unnecessary diagnostic testing are restraining the market growth.
Standalone CDSS segment holds the largest market share over the forecast period.
On the basis of product, the global clinical decision support systems market is segmented into standalone CDSS, integrated HER with CDSS. Among these, the standalone CDSS segment holds the largest market share over the forecast period owing its cost effectiveness and simplicity. Due to its easy to use feature in clinics and hospitals, the standalone CDSS segment is witnessing a significant growth. CDSS products are available in the market either in standalone form or integration with CPOE or EHR, or both.
Integrated HER with CDSS segment, on the other hand is anticipated to witness a significant growth owing to the increasing awareness as well as adoption of EHR by multi specialty healthcare units. Such systems offer patient history and database to CDSS that can offer suggest medicines and other clinical solutions to the practitioners which are automating the clinical workflow. CDSS and EHRs are used for streamlining the workflows and utilise the current data sets.
Drug allergy alert segment is dominating the market over the forecast period.
On the basis of application, the global clinical decision support systems market is segmented into drug-drug interactions, clinical reminders, drug allergy alerts, clinical guidelines, drug, dosing support, others. Among these, the drug allergy alert segment is dominating the market with the largest market share over the forecast period. Various people who are suffering from allergies to some drugs need some allergy alerts system. There could be a medicine error while prescribing, administering or dispensing a drug and the outcome can be worst.
The clinical guidelines segment is estimated to grow at a fastest rate. The CDS system provides guidelines regarding diagnosis and treatment. The system collected data from the knowledge vase and uses it for the further treatment and provide the clinical guidelines to the practitioners during the entire tenure of the treatment which is improving the quality of the treatment.
Delivery Mode Insights
Cloud based systems accounted the largest market share over the forecast period
Based on the delivery mode, the global clinical decision support systems market is segmented into web based systems, cloud based systems, and on premise systems. Among these, the cloud based systems accounted the largest market share over the forecast period due to the important innovations in the field of IT with potential applications in medical field. Apart from this, the cost effectiveness and reliability are also some of the other factors which are driving the market growth.
North America is dominating the market with the largest market share over the forecast period.
Get more details on this report -
The North America is dominating the market with the highest market share due to the increasing demand for healthcare IT solutions in the medical field. Apart from this, the advancements in the field of technology and the growing importance of offering high class healthcare services are augmenting the market growth.
Asia Pacific, on the other hand, is witnessing the fastest market growth owing the increasing investment made by the key market players in the healthcare industry. Certain countries like India, Japan, China, and Australia is witnessing huge growth due to the rising expenses in research and development activities to come up with new products for the people.
- In April 2021, Change Healthcare revealed InterQual 2021 which is the latest version of corporation’s flagship CDS solution.
- In May 2020, DHIndia has made an announcement about its partnership with EHRCIIITB & Healthlife for the development of a CDSS to screen COVID 19.
List of Key Companies
- Cerner Corporation
- McKesson Corporation
- Allscripts Healthcare, LLC
- Siemens Healthineers GmbH
- NextGen Healthcare Inc.
- Athenahealth, Inc.
- Koninklijke Philips N.V.
- Agfa Gevaert Group
- IBM Corporation
- Wolers Kluwer N.V.
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Clinical Decision Support Systems Market based on the below-mentioned segments:
Clinical Decision Support Systems Market, Product Analysis
- Standalone CDSS
- Integrated EHR with CDSS
Clinical Decision Support Systems Market, Application Analysis
- Drug-drug interactions
- Drug allergy alerts
- Clinical reminders
- Clinical guidelines
- Drug dosing support
Clinical Decision Support Systems Market, Delivery Mode Analysis
- Web based systems
- Cloud based systems
- On premise systems
Clinical Decision Support Systems Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions (FAQ)
1. What is the market size of Clinical Decision Support Systems Market?The global Clinical Decision Support Systems Market is expected to grow from USD 4.55 Billion in 2021 to USD 10.2 Billion by 2030, at a CAGR of 9.1% during the forecast period 2022-2030.
2. Which segment hold the largest market share?Cloud based segment hold the largest market share is going to continue its dominance.
3. Which region is dominating the Clinical Decision Support Systems Market?North America is dominating the Clinical Decision Support Systems Market with the highest market share.
Need help to buy this report?